| WKN: | A3D7VW |
| ISIN: | IE000S9YS762 |
| Land: | Irland |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Chemie |
|
DGAP Post-admission Duties announcement: Linde plc
/ Disclosure of share buy-backs in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052: 36. Interim Report
Disclosure of share buy-backs in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052: 36. Interim Report
1 Excluding costs incidental to the purchase. Further details about the buy-back program and the above transactions (including venues) are available on the investor relations section of Linde plc's website (https://investors.linde.com/stock-and-dividend-information/2021-2023-share-buyback, short URL: https://t1p.de/sharebuyback3) Guildford, United Kingdom, 12.10.2021 Linde plc
12.10.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
||||||||||||||||||||||||||||||||||||||||||
| Language: | English |
| Company: | Linde plc |
| The Priestley Centre, 10 Priestley Road | |
| GU2 7XY Guildford | |
| United Kingdom | |
| Internet: | www.linde.com |
| End of News | DGAP News Service |
|
|
1240242 12.10.2021
Quelle: DGAP